Showing results (1151-1160 of 1,764) with videos related to
Sort By:
Pageof 177
Cellular & Molecular Immunology|October 1, 2020
Clinical development of CAR T cell therapy in China: 2020 updateJianshu Wei, Yelei Guo, Yao Wang, et al.Cellular & Molecular Immunology|December 3, 2020
Immunological mechanisms and therapeutic targets of fatty liver diseasesHua Wang, Wajahat Mehal, Laura E Nagy, et al.Cellular & Molecular Immunology|November 13, 2020
The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune responseZhiwen Gu, Xueying Chen, Wenyong Yang, et al.Cellular & Molecular Immunology|July 16, 2021
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapyCai Zhang, Yuan Hu, Weihua Xiao, et al.Cellular & Molecular Immunology|June 12, 2021
Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA)Rongzeng Liu, Wei Jiang, Elizabeth D MellinsCellular & Molecular Immunology|October 12, 2020
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancerYongyan Chen, Zhigang TianCellular & Molecular Immunology|February 5, 2020
Three paralogous clusters of the miR-17~92 family of microRNAs restrain IL-12-mediated immune defenseXiang Zhang, Sinead M Smith, Xi Wang, et al.Cellular & Molecular Immunology|February 7, 2020
The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13Floriana Mulas, Xu Wang, Shanshan Song, et al.Cellular & Molecular Immunology|May 18, 2022
NADPH oxidase family proteins: signaling dynamics to disease managementRizwana Begum, Shilpa Thota, Abubakar Abdulkadir, et al.Cellular & Molecular Immunology|July 29, 2021
NLRP3 inflammasome activation and cell deathYi Huang, Wen Xu, Rongbin ZhouPageof 177